Clinical trial
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated…
NCT00384527 · Romark Laboratories L.C., Industry · Terminated
Key facts
| NCT number | NCT00384527 |
|---|---|
| Title | Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease |
| Official title | Multicenter, Double-blind Study of Nitazoxanide Compared to Vancomycin in the Treatment of Clostridium Difficile-associated Disease |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Clostridium Infections |
| Intervention type | Drug |
| Interventions | Nitazoxanide, Vancomycin |
| Enrollment | 50 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Oct 6, 2006 |
| Last update posted | May 5, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: